Literature DB >> 24378774

Renal angiotensin-converting enzyme and blood pressure control.

Kenneth E Bernstein1, Jorge F Giani, Xiao Z Shen, Romer A Gonzalez-Villalobos.   

Abstract

PURPOSE OF REVIEW: This review presents novel findings regarding the renal angiotensin-converting enzyme (ACE) and its role in blood pressure (BP) control. RECENT
FINDINGS: The textbook flow diagram of the renin-angiotensin system (RAS) shows the pulmonary endothelium as the main source of the ACE that converts angiotensin I to angiotensin II. However, ACE is made in large quantities by the kidneys, which raises the important question of what precisely is the function of renal ACE? Recent studies in gene-targeted mice indicates that renal ACE plays a dominant role in regulating the response of the kidney to experimental hypertension. In particular, renal ACE and locally generated angiotensin II affect the activity of several key sodium transporters and the induction of sodium and water retention resulting in the elevation of BP.
SUMMARY: New experimental data link the renal ACE/angiotensin II pathway and the local regulation of sodium transport as key elements in the development of hypertension.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24378774      PMCID: PMC4028050          DOI: 10.1097/01.mnh.0000441047.13912.56

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  60 in total

Review 1.  Molecular mechanisms of human hypertension.

Authors:  R P Lifton; A G Gharavi; D S Geller
Journal:  Cell       Date:  2001-02-23       Impact factor: 41.582

2.  Regulation of macula densa Na:H exchange by angiotensin II.

Authors:  J Peti-Peterdi; P D Bell
Journal:  Kidney Int       Date:  1998-12       Impact factor: 10.612

3.  Increased urinary angiotensinogen is precedent to increased urinary albumin in patients with type 1 diabetes.

Authors:  Toshie Saito; Maki Urushihara; Yumiko Kotani; Shoji Kagami; Hiroyuki Kobori
Journal:  Am J Med Sci       Date:  2009-12       Impact factor: 2.378

4.  Angiotensin II acts through the angiotensin 1a receptor to upregulate pendrin.

Authors:  Jill W Verlander; Seongun Hong; Vladimir Pech; James L Bailey; Diana Agazatian; Sharon W Matthews; Thomas M Coffman; Thu Le; Tadashi Inagami; Florence M Whitehill; I David Weiner; Donna B Farley; Young Hee Kim; Susan M Wall
Journal:  Am J Physiol Renal Physiol       Date:  2011-09-14

5.  Mice lacking endothelial angiotensin-converting enzyme have a normal blood pressure.

Authors:  Justin Cole; Du Le Quach; Karthik Sundaram; Pierre Corvol; Mario R Capecchi; Kenneth E Bernstein
Journal:  Circ Res       Date:  2002-01-11       Impact factor: 17.367

6.  Angiotensin I-converting enzyme activity in tubular fluid along the rat nephron.

Authors:  D E Casarini; M A Boim; R C Stella; M H Krieger-Azzolini; J E Krieger; N Schor
Journal:  Am J Physiol       Date:  1997-03

7.  Mice with cardiac-restricted angiotensin-converting enzyme (ACE) have atrial enlargement, cardiac arrhythmia, and sudden death.

Authors:  Hong D Xiao; Sebastien Fuchs; Duncan J Campbell; William Lewis; Samuel C Dudley; Vijaykumar S Kasi; Brian D Hoit; George Keshelava; Hui Zhao; Mario R Capecchi; Kenneth E Bernstein
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

8.  Changes in single nephron renin release are mediated by tubular fluid flow rate.

Authors:  P P Leyssac
Journal:  Kidney Int       Date:  1986-09       Impact factor: 10.612

9.  Increased blood pressure in transgenic mice expressing both human renin and angiotensinogen in the renal proximal tubule.

Authors:  Julie L Lavoie; Kristy D Lake-Bruse; Curt D Sigmund
Journal:  Am J Physiol Renal Physiol       Date:  2004-01-13

10.  Intrarenal mouse renin-angiotensin system during ANG II-induced hypertension and ACE inhibition.

Authors:  Romer A Gonzalez-Villalobos; Ryousuke Satou; Naro Ohashi; Laura C Semprun-Prieto; Akemi Katsurada; Catherine Kim; G M Upchurch; Minolfa C Prieto; Hiroyuki Kobori; L Gabriel Navar
Journal:  Am J Physiol Renal Physiol       Date:  2009-10-21
View more
  10 in total

1.  Hepatic and renal mechanisms underlying the osmopressor response.

Authors:  Tu H Mai; Emily M Garland; André Diedrich; David Robertson
Journal:  Auton Neurosci       Date:  2017-01-27       Impact factor: 3.145

2.  Association of ACE polymorphism and diabetic nephropathy susceptibility.

Authors:  Hongbo Ma; Che Yu; Rong Wang
Journal:  Int J Clin Exp Med       Date:  2015-02-15

Review 3.  Intrarenal Angiotensin-Converting Enzyme: the Old and the New.

Authors:  Silas Culver; Caixia Li; Helmy M Siragy
Journal:  Curr Hypertens Rep       Date:  2017-09-19       Impact factor: 5.369

4.  Long-term antihypertensive effects of far-infrared ray irradiated from wooden board in spontaneously hypertensive rats.

Authors:  Chien-Tsong Lin; Ming-Ju Lin; Yung-Pin Chen; Ko-Chao Lee; Kuo-Chin Huang; Shun-Fu Chang; Cheng-Nan Chen
Journal:  BMC Complement Altern Med       Date:  2016-02-08       Impact factor: 3.659

Review 5.  Salvia miltiorrhiza: A Potential Red Light to the Development of Cardiovascular Diseases.

Authors:  Lili Wang; Rufeng Ma; Chenyue Liu; Haixia Liu; Ruyuan Zhu; Shuzhen Guo; Minke Tang; Yu Li; Jianzhao Niu; Min Fu; Sihua Gao; Dongwei Zhang
Journal:  Curr Pharm Des       Date:  2017       Impact factor: 3.116

6.  Stevioside modulates oxidative damage in the liver and kidney of high fat/low streptozocin diabetic rats.

Authors:  Solomon Oladapo Rotimi; Oluwakemi Anuoluwapo Rotimi; Isaacson Bababode Adelani; Chinonye Onuzulu; Patience Obi; Rotimi Okungbaye
Journal:  Heliyon       Date:  2018-05-31

7.  Novel Angiotensin-Converting Enzyme-Inhibitory Peptides From Fermented Bovine Milk Started by Lactobacillus helveticus KLDS.31 and Lactobacillus casei KLDS.105: Purification, Identification, and Interaction Mechanisms.

Authors:  Jiaqi Li; Jiajia Zhao; Xindi Wang; Abdul Qayum; Muhammad Altaf Hussain; Guizhao Liang; Juncai Hou; Zhanmei Jiang; Aili Li
Journal:  Front Microbiol       Date:  2019-11-28       Impact factor: 5.640

8.  Fimasartan, an angiotensin II receptor antagonist, ameliorates an in vivo zebrafish model of heart failure.

Authors:  Hailian Quan; Gyu Chul Oh; Seung Hyeok Seok; Hae-Young Lee
Journal:  Korean J Intern Med       Date:  2020-03-13       Impact factor: 2.884

9.  Angiotensin(1-7) activates MAS-1 and upregulates CFTR to promote insulin secretion in pancreatic β-cells: the association with type 2 diabetes.

Authors:  Xue-Lian Zhang; Xinyi Zhao; Yong Wu; Wen-Qing Huang; Jun-Jiang Chen; Peijie Hu; Wei Liu; Yi-Wen Chen; Jin Hao; Rong-Rong Xie; Hsiao Chang Chan; Ye Chun Ruan; Hui Chen; Jinghui Guo
Journal:  Endocr Connect       Date:  2022-01-11       Impact factor: 3.335

10.  Peperomia pellucida (L.) Kunth as an angiotensin-converting enzyme inhibitor in two-kidney, one-clip Goldblatt hypertensive rats.

Authors:  Fadlina Chany Saputri; Irma Hutahaean; Abdul Mun'im
Journal:  Saudi J Biol Sci       Date:  2021-06-30       Impact factor: 4.219

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.